Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RADX compared with CRIS: revenue, margins and what each company keeps, and the suppliers and customers both name
RADX
Radiopharm Theranostics Ltd
Change
Mkt cap
Revenue
Revenue
CRIS
Curis Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
RADX
Radiopharm Theranostics Ltd
vs
CRIS
Curis Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RADX: latest quarter not drawable. CRIS: latest quarter not drawable.
Method
›
RADX
Radiopharm Theranostics Ltd
Change
0.90
▼
−9.37%
Mkt cap
$3.5B
Revenue
—
Revenue
—
CRIS
Curis Inc
Change
0.92
▲
+39.82%
Regular session
Nov 3 '26
Mkt cap
$1.4M
Revenue
$1M
Q4 FY25
Revenue
$9M
FY25
vs
Compare
Regular session
Nov 3 '26
RADX
Radiopharm Theranostics Ltd
vs
CRIS
Curis Inc
0.90
▼
−9.37%
Price
0.92
▲
+39.82%
$3.5B
Mkt cap
$1.4M
—
Revenue
$1M
Q4 FY25
—
Revenue
$9M
FY25
Change
Change
RADX
0.90
▼
−9.37%
vs
CRIS
0.92
▲
+39.82%
Regular session
Nov 3 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RADX, solid
CRIS, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RADX
3
—
AtomVie
unlisted
supplier
—
Diaprost AB
unlisted
supplier
—
Lantheus
unlisted
customer
Shared
0
No shared counterparties.
Only CRIS
1
—
Genentech
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR